Veracyte, headquartered in South San Francisco, develops diagnostic products for various cancers and employs 815 people. The company went public in 2013 and offers tests like Afirma and Decipher.
Phillip G Febbo sold 8,037 shares of VCYT on 4 March at $33.95 per share, worth a total of $273K. They now own 86,110 VCYT shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
